Chronic Kidney Disease
Test employs AI to assess kidney disease risk among adults with type 2 diabetes
How physicians assess chronic kidney disease and its progression among adults with type 2 diabetes may be changing due to a new prognostic tool.
Primary care intervention through commercial health plan may improve CKD management, reduce costs
A quality improvement intervention — integrated into BlueCross BlueShield’s CareFirst patient-centered medical home model — provided benefits to patients with advanced CKD, including decreased hospitalizations and reduced medical costs.
Kidney function improves more among women vs men with sleep apnea treatment
Published research suggests, due to sex differences in kidney function, women may gain more renal benefits from sleep apnea treatment than men.
Children with CKD prescribed nephrotoxic medications at high rates in primary care practices
A recently published study found primary care physicians prescribed nephrotoxic medications to children with chronic kidney disease at a rate four-times greater than they did to those without the disease.
Oral difelikefalin shows benefits in patients with CKD-related pruritus
Cara Therapeutics recently announced phase 2 trial results that demonstrated its oral form of difelikefalin safely reduced itch intensity for patients with chronic kidney disease.
Coffee may reduce risk for kidney disease
Recently published findings suggest coffee consumption may provide a beneficial effect on kidney function, thereby reducing the risk for developing chronic kidney disease.
Southwest Nephrology-Cardio Renal Metabolic Conference focuses on inhibitors, dialysis and cross-specialty care
Under the leadership of President Peter McCullough, MD, The Cardio Renal Society of America’s mission is to prevent and manage three potentially chronic conditions that often coexist: kidney disease, cardiovascular disease and diabetes.
eGFR decline greater with albuminuria plus normal renal function than nonalbuminuric CKD in diabetes
Among a cohort of adults with type 2 diabetes, estimated glomerular filtration rate fell to a lesser degree among those with chronic kidney disease and no albuminuria vs. those without CKD and those with albuminuria. Furthermore, end-stage renal disease risk was not different between adults with CKD and no albuminuria and those without CKD, according to findings published in Diabetes Care.
Study: Gadolinium-enhanced MRI poses low risk of nephrogenic systemic fibrosis
The risk of developing nephrogenic systemic fibrosis was low with the use of gadolinium-based contrast agents for MRI in patients with CKD, according to a recently published study.